| miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM. | miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM.
Hao H, Wang B, Yang L, Sang Y, Xu W, Liu W, Zhang L, Jiang D., Free PMC Article | 08/7/2023 |
| The mucin protein MUCL1 regulates melanogenesis and melanoma genes in a manner dependent on threonine content. | The mucin protein MUCL1 regulates melanogenesis and melanoma genes in a manner dependent on threonine content.
Kim J, Choi H., Free PMC Article | 04/30/2022 |
| Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating betacatenin and increases irinotecan sensitivity in colorectal cancer. | Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating β‑catenin and increases irinotecan sensitivity in colorectal cancer.
Abdulla M, Traiki TB, Vaali-Mohammed MA, El-Wetidy MS, Alhassan N, Al-Khayal K, Zubaidi A, Al-Obeed O, Ahmad R., Free PMC Article | 03/26/2022 |
| Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelialtomesenchymal transition. | Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial‑to‑mesenchymal transition.
Li QH, Liu ZZ, Ge YΝ, Liu X, Xie XD, Zheng ZD, Ma YH, Liu B., Free PMC Article | 05/8/2021 |
| an important role for MUCL1 in the proliferation of breast cancer cells | HER2 drives Mucin-like 1 to control proliferation in breast cancer cells.
Conley SJ, Bosco EE, Tice DA, Hollingsworth RE, Herbst R, Xiao Z., Free PMC Article | 08/19/2017 |
| SBEM has the potential to be a specific marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer. | Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer.
Liu ZZ, Xie XD, Qu SX, Zheng ZD, Wang YK. | 06/14/2010 |
| The SBEM might a suitable marker for molecular detection of ITCs in BM in breast cancer patients. Analysis of prognostic value for SBEM mRNA-based assay should take into account the heterogeneity and different molecular subtypes of breast cancer. | Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
Valladares-Ayerbes M, Iglesias-Díaz P, Díaz-Prado S, Ayude D, Medina V, Haz M, Reboredo M, Antolín S, Calvo L, Antón-Aparicio LM. | 01/21/2010 |
| results demonstrate that SBEM mRNA may be an important marker for targeting breast cancer micrometastasis | In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer.
Ayerbes MV, Díaz-Prado S, Ayude D, Campelo RG, Iglesias P, Haz M, Medina V, Gallegos I, Quindós M, Aparicio LA. | 01/21/2010 |
| SBEM may identify a unique subset of breast cancers with poor prognosis and have implications for therapeutic management. | Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers.
Skliris GP, Hubé F, Gheorghiu I, Mutawe MM, Penner C, Watson PH, Murphy LC, Leygue E, Myal Y., Free PMC Article | 01/21/2010 |
| octamer-binding transcription factors participate in the strong expression of SBEM gene in breast tissues | Identification of an octamer-binding site controlling the activity of the small breast epithelial mucin gene promoter.
Hubé F, Chooniedass-Kothari S, Hamedani MK, Miksicek RJ, Leygue E, Myal Y. | 01/21/2010 |
| identification as possible new breast tumor biomarker | Human small breast epithelial mucin: the promise of a new breast tumor biomarker.
Hubé F, Mutawe M, Leygue E, Myal Y. | 01/21/2010 |